Natco Pharma Tentative Approval for Erdafitinib Tablets
Natco Pharma has received tentative approval for Erdafitinib tablets (3 mg, 4mg, and 5 mg), a generic version of Balversa®. The drug is…
Kalyani Steels Q3 FY26 Results – Profit After Tax at ₹613.18 Million
Kalyani Steels announced its unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025.…
Coromandel International Promoter Group Reclassification Request
Coromandel International has applied for the reclassification of Algavista Greentech Private Limited (AGPL) from the ‘Promoter…
Aditya Birla Capital Grants Employee Stock Options and Performance Stock Units
Aditya Birla Capital has announced the grant of Employee Stock Options (Stock Options) and Employee Performance Stock Units (PSUs) under its…
Eicher Motors Board to Consider Q3 2026 Financial Results
Eicher Motors has announced that a Board meeting will be held on February 10, 2026, to consider and approve the unaudited standalone and…
Zydus Wellness Net Sales Surge 113.7% in Q3 FY26
Zydus Wellness reported a 113.7% surge in net sales, reaching Rs. 9,633 mn in Q3 FY26. EBITDA stood at Rs 610 mn, reflecting a 312.2%…
Schaeffler India Achieves ESG Score of 78 in S&P Global Assessment
Schaeffler India has been assigned an ESG Score of 78 out of 100 by S&P Global, following a Corporate Sustainability Assessment (CSA).…
Zydus Wellness Q3 FY26 Results – Strong Growth in Domestic Business
Zydus Wellness reported a revenue of ₹9,633 million in Q3 FY26, a 113.7% increase year-over-year. The domestic business saw substantial…
MMTC Board to Consider Unaudited Financial Results for Quarter Ended December 31, 2025
MMTC has announced that its Board Meeting will be held on February 12, 2026, to consider and approve the unaudited financial results for the…
Five-Star Business Finance Earnings Conference Call Transcript – Q3 FY26
Five-Star Business Finance reported its Q3 FY26 results, detailing a focus on stabilizing collections and managing asset quality during…